330 related articles for article (PubMed ID: 7511760)
1. Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
Mohabir R; Young SD; Strosberg AM
J Cardiovasc Pharmacol; 1994 Feb; 23(2):291-9. PubMed ID: 7511760
[TBL] [Abstract][Full Text] [Related]
2. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
Ruzicka M; Yuan B; Harmsen E; Leenen FH
Circulation; 1993 Mar; 87(3):921-30. PubMed ID: 8443912
[TBL] [Abstract][Full Text] [Related]
3. Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats.
Ruzicka M; Yuan B; Leenen FH
Circulation; 1994 Jul; 90(1):484-91. PubMed ID: 8026035
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the angiotensin II type 1-receptor antagonist YM358 and the angiotensin-converting enzyme inhibitor enalapril in rats with cardiac volume overload.
Tokioka-Akagi T; Fujimori A; Shibasaki M; Inagaki O; Yanagisawa I
Jpn J Pharmacol; 2001 May; 86(1):79-85. PubMed ID: 11430476
[TBL] [Abstract][Full Text] [Related]
5. Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload.
Ishiye M; Umemura K; Uematsu T; Nakashima M
Biol Pharm Bull; 1995 May; 18(5):700-4. PubMed ID: 7492986
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats.
Ruzicka M; Leenen FH
Am J Physiol; 1993 Nov; 265(5 Pt 2):H1551-6. PubMed ID: 8238566
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
Makino N; Sugano M; Otsuka S; Hata T
Hypertension; 1997 Oct; 30(4):796-802. PubMed ID: 9336375
[TBL] [Abstract][Full Text] [Related]
8. Differential suppression of pressure-overload cardiac and aortic hypertrophy in rats by angiotensin-converting enzyme inhibitors.
Wang DQ; Kakizoe E; Kobayashi Y; Shimoura K; Okunishi H
Jpn J Pharmacol; 1999 Aug; 80(4):333-42. PubMed ID: 10496334
[TBL] [Abstract][Full Text] [Related]
9. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
[TBL] [Abstract][Full Text] [Related]
10. Chronic low-dose treatment with enalapril induced cardiac regression of left ventricular hypertrophy.
Makino N; Sugano M; Hata T; Taguchi S; Yanaga T
Mol Cell Biochem; 1996; 163-164():239-45. PubMed ID: 8974063
[TBL] [Abstract][Full Text] [Related]
11. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice.
Rockman HA; Wachhorst SP; Mao L; Ross J
Am J Physiol; 1994 Jun; 266(6 Pt 2):H2468-75. PubMed ID: 8024008
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin.
Ishiye M; Umemura K; Uematsu T; Nakashima M
Eur J Pharmacol; 1995 Jun; 280(1):11-7. PubMed ID: 7498249
[TBL] [Abstract][Full Text] [Related]
13. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
Haddad G; Amiri F; Garcia R
Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
[TBL] [Abstract][Full Text] [Related]
14. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
Li JS; Sharifi AM; Schiffrin EL
J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
[TBL] [Abstract][Full Text] [Related]
15. The renin-angiotensin system and volume overload-induced changes in cardiac collagen and elastin.
Ruzicka M; Keeley FW; Leenen FH
Circulation; 1994 Oct; 90(4):1989-96. PubMed ID: 7923689
[TBL] [Abstract][Full Text] [Related]
16. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Yukimura T; Miura K; Iwao H
Br J Pharmacol; 1996 Jun; 118(3):549-56. PubMed ID: 8762077
[TBL] [Abstract][Full Text] [Related]
17. Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in rats.
Linz W; Henning R; Schölkens BA
J Hypertens Suppl; 1991 Dec; 9(6):S400-1. PubMed ID: 1840203
[No Abstract] [Full Text] [Related]
18. Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat.
Huang W; Alhenc Gelas F; Osborne-Pellegrin MJ
Circ Res; 1998 May; 82(8):879-90. PubMed ID: 9576107
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Mediation by the AT1 receptor.
Dostal DE; Baker KM
Am J Hypertens; 1992 May; 5(5 Pt 1):276-80. PubMed ID: 1533768
[TBL] [Abstract][Full Text] [Related]
20. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats.
Gohlke P; Kuwer I; Schnell A; Amann K; Mall G; Unger T
Hypertension; 1997 Jan; 29(1 Pt 2):478-82. PubMed ID: 9039145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
